Indirect impact of the COVID-19 pandemic on diabetes-related lower extremity amputations: A regional study
Yılmaz Ergişi, Erdi Özdemir1, Ozan Altun
1Karabük Üniversitesi Tıp Fakültesi Ortopedi ve Travmatoloji Anabilim Dalı, 78100 Karabük, Türkiye. erdi.ozdemir@hacettepe.edu.tr.
Insights
The COVID-19 pandemic did not significantly alter lower extremity amputation levels in diabetes patients. Patient adherence to medical care remains the primary factor influencing amputation surgery outcomes.
Area of Science:
- Medical Research
- Public Health
- Diabetology
Background:
- The COVID-19 pandemic disrupted routine healthcare access globally.
- Diabetes patients are at high risk for lower extremity complications requiring amputation.
Purpose of the Study:
- To assess the indirect impact of the COVID-19 pandemic on diabetes-related lower extremity amputations.
- To compare amputation levels and incidence between pre-pandemic and pandemic periods.
Main Methods:
- Retrospective review of patients undergoing lower limb amputation due to diabetes complications.
- Comparison of two groups: pre-pandemic (Aug 2019-Feb 2020) and pandemic (Aug 2020-Feb 2021).
- Analysis of amputation levels and time since last diabetes follow-up.
Main Results:
- No statistically significant difference in amputation levels between control and pandemic groups (p=0.959).
- A significant increase in the mean time from last diabetes control to amputation in the pandemic group (p=0.038).
- No significant difference in the proportion of patients without diabetes follow-up in the year prior to amputation (p=0.842).
Conclusions:
- The COVID-19 pandemic did not indirectly affect the level or incidence of lower extremity amputations in diabetes patients.
- Delays in routine diabetes care during the pandemic did not lead to increased amputation severity.
- Patient adherence to diabetes management is the key determinant for preventing amputation surgery.
Objectives:
This study aims to evaluate the indirect impact of the novel coronavirus disease 2019 (COVID-19) pandemic on diabetes-related lower extremity amputations.
Patients And Methods:
Patients who underwent lower limb amputation due to complications of diabetes between August 2019 and February 2020 (control group) and August 2020 and February 2021 (pandemic group) were retrospectively reviewed. None of the patients had a previous COVID-19 infection. Patients' amputation level and latest diabetes follow-up date until amputation were recorded.
Results:
A total of 19 feet of 19 patients (14 males, 5 females; mean age: 70.0±10.5 years; range, 53 to 91 years) in the control group and 18 feet of 18 patients (12 males, 6 females; mean age: 70.4±11.3 years; range, 54 to 91 years) were included. There was no statistically significant difference in amputation levels between the two groups (p=0.959). The mean time elapsed from the last diabetes control in the control and the pandemic group was 5.9±12.8 months and 8.2±9.8 months, respectively (p=0.038). A total of eight (42.1%) patients in the control group and seven (38.9%) patients in the pandemic group did not have a follow-up for diabetes in the last year prior to amputation (p=0.842).
Conclusion:
Although the COVID-19 pandemic seems to cause a delay in the routine medical care of patients with diabetes, it appears not to have an indirect effect on the lower extremity amputation level and incidence. Patients' adherence may be the major determinant in amputation surgery.
More Related Videos
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Peripheral Artery Disease III: Interprofessional Care
Diabetes: Symptoms, Diagnosis, and Complications
